Paediatric Clinical Trials 2017

Paediatric Clinical Trials is organized by SMi Group and would be held during Mar 20 - 21, 2017 at Copthorne Tara Hotel, London, England, United Kingdom.

Strengthening strategies in paediatric investigation plans remains paramount and with the EMA 10 year review of paediatric regulation a call has been made for greater guidance with the goal of increasing the number of safe paediatric therapeutics on the market.

Join us as we discuss current clinical trials, implementation and paediatric drug development in a series of interactive conference sessions, roundtables and workshops led by leading industry experts. Gain information on methods to improve clinical recruitment, appreciate ethical issues and navigate regulations when planning and executing a paediatric clinical trial. They will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.

Benefits of Attending :
• Review and discuss paediatric clinical trial Legislation in the EU and globally
• Explore the practical costs and safety considerations of conducting a paediatric clinical trial
• Review the challenges in paediatric drug development for oncology drugs and vaccines
• Optimise your approach to paediatric formulation to improve clinical success
• Evaluate approaches for recruitment and retention

• Gain an in-depth update from the EMA on the PDCO's 10 year review into paediatric investigation plans
• Review and discuss paediatric clinical trial legislation in the EU and US
• Join GSK in reviewing the challenges in paediatric drug development for rare diseases
• Hear Roche discuss how clinical outcome assessments can lead to patient - centred paediatric clinical trials
• Optimise your approach to paediatric drug formulation to improve clinical success

CHAIRS FOR 2017 :
Robb Kahn, Former, Senior Safety Science Leader, Global Paediatric Oncology Drug Development, Genentech/Roche
Philippe Auby, CEO and President, OEDC (Otsuka Europe Development and Commercialisation), Otsuka Europe

Keynote Speakers Include :
Bianca McDade, Director Regulatory Affairs, GSK
Tom Willgoss, Senior Outcomes Research Scientist,  Patient-Centred Outcomes Research, Roche
Karl- Heinz Huemer, Scientifi c Committee Member and Expert, EMA Austria
Hernando Patino, Paediatric Drug Development Lead, Johnson and Johnson
Deborah Lee, VP Clinical Development,
Insys Therapeutics

Don't miss post-conference workshop: Paediatric drug development :
Paediatric Investigation Plans (PIPs), challenges and strategies

Prices :
Conference only : GBP 1499
Workshop only: GBP 599
Conference + Workshop : GBP 2098

Speakers : Genetech, Roche, Otsuka Europe, GSK, Roche, Johnson and Johnson, Insys Therapeutics